Joseph Alvarnas, MD, Discusses New CMS Drug Pricing Models, Impact for Blood Diseases
CMS in February 2023 announced 3 new models for testing by the Center for Medicare & Medicaid Innovation—all of which “aim to lower the cost of drugs, promote accessibility to life-changing drug therapies, and improve quality of care.”
Source: ajmc.com